Welcome to our dedicated page for FOIL news (Ticker: FOIL), a resource for investors and traders seeking the latest updates and insights on FOIL stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FOIL's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FOIL's position in the market.
Londian Wason (NYSE: FOIL) priced its upsized U.S. initial public offering at $22.00 per American depositary share, selling approximately 4.3 million ADSs for expected gross proceeds of $94.3 million and net proceeds of about $87.0 million, excluding any underwriter option exercise.
The underwriters have a 30‑day option to buy up to 642,857 additional ADSs. Trading on the NYSE is expected to begin on August 12, 2026 under ticker FOIL, with closing targeted for August 13, 2026, subject to customary conditions. Proceeds are intended for production expansion, facility upgrades, R&D, manufacturing efficiency, product expansion, and general corporate purposes.